Sunday, 8th September 13th Australian Peptide Conference 2019

• The oncogenic lncRNA RP11-499F3.2 promotes tumorigenesis and cetuximab resistance via activation of Wnt2B signaling  - Hanmei Xu
• Mediator Lipidomics: Towards Comprehensive Metabolic Profiling of Eicosanoids and Related Fatty Acids - Atsuhiko 'Ash' Toyama
• Reforming the Regulatory Environment for Innovative Health Technologies: Identifying Congestion and Filling Gaps - Jane Nielsen
• Patentomics: personalised protection - Simone Vink

• When metalloproteins go rogue: application of metalloproteomics to understand Neurodegeneration - Larissa Lago
• ProCan®: from cancer tissue proteomics to clinical application. - Rosemary Balleine
• Towards liquid biopsy screening for esophageal adenocarcinoma - Michelle Hill
• Alzheimer’s Disease – an Assay Odyssey - Darren M Weber

• Examples of how a novel surface chemistry enables gold surface biosensors to carry out selective early diagnosis: In search of Eldorado  - Malcolm Buckle
• Optical biosensors that provide new insights into biomembrane-mediated events - Mibel Aguilar
• Integrated omics for tissue-based mapping of the human proteome - Cecilia Lindskog

• Accelerating DIA Using Fast Microflow LC Gradients for Large Scale Quantitative Proteomics - Christie Hunter
• Ion mobility-mass spectrometry: An added dimension for structural biology in the context of protein aggregation - Tara L Pukala
• New Cryo-EM methods present exciting challenges for the ‘Omics communities  - James Whisstock

Rest break, no catering. 

• Customizing macromolecules through chemical ligation  - Philip Dawson
• Targeting Sodium Channels for the Treatment of Pain - Nieng Yan